ImmuCell settles insurance claim for $426,587; total recovery $676,587 from contamination events

IMMUCELL CORP /DE/

Settlement of $426,587 received for production contamination losses from late 2022 through April 2024.
This amount is in addition to the $250,000 previously recognized in Q3 2023, bringing total claim recovery to $676,587.
The insurance claim was long outstanding; settlement resolves coverage for previously disclosed contamination events.
Company plans to report Q4 and full-year 2024 results on conference call February 26, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.